bpc 157 human clinical trial musculoskeletal injury The “Wolverine” Drug – Ortho Rhode Island Pentadecapeptide BPC 157 Enhances the
Description
Get it wrong and you are guessing for the life of the vial
Human case reports and pilot studies suggest benefits at 100300 mg/day ranges for cognitive support and metabolic health [13]
Cascade of immune mechanism and consequences of inflammatory disorders
Its ideal for chronic pain, tendon injuries, GI dysfunction, and even post-surgery recovery
